Target intelligence / Profile preview

Osteogenic cell attachment and activation (Null)

Target
Null
Molecular classification
Receptor, Other
01

Overview

Osteogenic cell attachment and activation is a critical process in bone repair and regeneration, involving the binding of osteogenic precursor cells (osteoblasts, osteoprogenitors) to extracellular matrix or implanted scaffolds via specific integrin receptors, predominantly α2β1 and α5β1 integrins. Upon attachment, these receptors initiate intracellular signaling (e.g., focal adhesion kinase phosphorylation, MAPK activation) that promotes cell survival, proliferation, and eventual differentiation into bone-forming cells. Synthetic peptides (e.g., P-15) mimic collagen binding sites to enhance this process, leading to improved outcomes in bone grafting and repair[3][5]. The process is essential for physiological bone healing and is targeted in regenerative medicine but, as named, it is not a specific "therapeutic target" but rather a coordinated cellular process involving multiple molecules[3][5][8].

Other names
Osteoblast attachmentBone cell-ECM interactionIntegrin-mediated osteogenesis
02

Mechanism of action

Promotion of cell adhesion by integrin-collagen interaction Activation of intracellular signaling cascades (including focal adhesion kinase, MAPK, and downstream osteogenic transcription factors such as Runx2 and Smads[3][1][2])

03

Biological functions

Cell adhesionCell signaling/activationOsteogenic differentiationTissue regeneration
04

Disease associations

Bone healing and regenerationOsteoporosis (impaired attachment/activation)Orthopedic implant integration
05

Safety considerations

Non-specific cell activation causing fibrosis or unwanted ossification (ectopic bone formation)Potential immune reaction to scaffold or peptide materials (e.g., synthetic P-15 in bone grafts)
06

Interacting drugs

P-15 (synthetic collagen peptide used in bone grafts to enhance osteogenic cell attachment)

1 more in the full profile.

07

Biomarkers

Expression of integrin subunits (α2, α5, β1)Focal adhesion kinase activation/phosphorylationOsteoblast gene markers: alkaline phosphatase, osteocalcin

Beyond the preview

Go deeper on Osteogenic cell attachment and activation (Null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Osteogenic cell attachment and activation (Null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call